EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Ticagrelor-Associated Central Sleep Apnea: Mechanisms, Clinical Evidence, and Implications for Sleep Medicine

Binh Pham

Cureus · 09.11.2026

DOI: 10.7759/cureus.119361 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 09.11.2026. Verfasst von Binh Pham. Beteiligte Einrichtung: Psychiatry, Western University of Health Sciences, Pomona, USA. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ticagrelor is a reversible P2Y12 receptor antagonist used for antiplatelet therapy and is well recognized to cause dyspnea. Emerging concern has focused on a possible association between ticagrelor and central sleep apnea, Cheyne-Stokes respiration, and other manifestations of ventilatory instability. This narrative review examines the clinical evidence for ticagrelor-associated central sleep apnea and the respiratory-control mechanisms proposed to underlie this association. A structured literature search was performed using PubMed, with Google Scholar and citation tracking used for supplementary discovery. Human clinical, physiologic, pharmacovigilance, and mechanistic evidence was synthesized qualitatively according to study design and evidentiary strength. Overall, the literature supports a possible association between ticagrelor exposure and central respiratory instability, although the incidence, clinical significance, and susceptibility factors remain uncertain. Enhanced ventilatory chemosensitivity and ventilatory overshoot provide a plausible physiologic framework, whereas equilibrative nucleoside transporter 1 inhibition and altered adenosine signaling remain proposed rather than established mechanisms in humans. Ticagrelor-associated central sleep apnea should therefore be regarded as an emerging medication-associated respiratory phenotype requiring cautious clinical interpretation. Prospective studies using standardized respiratory phenotyping, appropriate comparator groups, serial assessment, and clinically meaningful outcomes are needed to clarify susceptibility, reversibility, mechanisms, and clinical consequences.

Schlagwörter

Stichwörter der Autor:innen

adenosinecentral sleep apneacheyne-stokes respirationloop gainp2y12 inhibitorsperiodic breathingrespiratory controlsleep-disordered breathingticagrelorventilatory chemosensitivity

Autor:innen und Institutionen

  • Psychiatry, Western University of Health Sciences, Pomona, USA.
  • Sleep Medicine, Amen Clinics, Costa Mesa, USA.
  • Sleep Medicine, Southwest Healthcare Medical Education Consortium, Temecula, USA.

Zitieren

APA

Pham, B. (2026). Ticagrelor-Associated Central Sleep Apnea: Mechanisms, Clinical Evidence, and Implications for Sleep Medicine. Cureus. https://doi.org/10.7759/cureus.119361

Vancouver

Pham B. Ticagrelor-Associated Central Sleep Apnea: Mechanisms, Clinical Evidence, and Implications for Sleep Medicine. Cureus. 2026. doi:10.7759/cureus.119361

BibTeX
@article{Pham2026,
  author = {Pham, Binh},
  title = {Ticagrelor-Associated Central Sleep Apnea: Mechanisms, Clinical Evidence, and Implications for Sleep Medicine},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119361}
}
Kostenlos starten →